- Markets
- Engineering & Capital Goods
- JPASSOCIAT
JPASSOCIAT
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Jaiprakash Associates Dec-Quarter Consol Net Loss After Tax 7.64 Billion Rupees
Feb 14 (Reuters) - Jaiprakash Associates Ltd JAIA.NS:
DEC-QUARTER CONSOL NET LOSS AFTER TAX 7.64 BILLION RUPEES
DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 14.91 BILLION RUPEES
Source text: [ID:]
Further company coverage: JAIA.NS
(([email protected];))
Feb 14 (Reuters) - Jaiprakash Associates Ltd JAIA.NS:
DEC-QUARTER CONSOL NET LOSS AFTER TAX 7.64 BILLION RUPEES
DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 14.91 BILLION RUPEES
Source text: [ID:]
Further company coverage: JAIA.NS
(([email protected];))
India's Max Healthcare rises on plans to buy stake in Jaypee Healthcare
** Shares of Max Healthcare MAXE.NS rise about 2.5% to 954 rupees apiece
** The hospital chain on Friday announced an agreement with Lakshdeep Group to buy a 64% stake in Jaypee Healthcare at an enterprise value of 16.60 bln rupees ($198.31 mln)
** Jaypee Healthcare is currently undergoing the corporate insolvency resolution process
** Acquisition expands presence of MAXE in Noida and is in line with the strategy to leverage cash to boost growth through inorganic initiatives, says Ambit
** Brokerage terms it its second best pick in hospitals segment after Narayana Hrudayalaya NARY.NS
** The mean recommendation of 16 analysts tracking MAXE is "buy"; target price is at 947.50 rupees, around current levels - LSEG data
** Stock up 39% in 2024 so far, mirroring the performance of Nifty healthcare index .NIFHEIN - Exchange data
($1 = 83.7080 Indian rupees)
(Reporting by Bharath Rajeswaran in Bengaluru)
(([email protected]; +91 9769003463;))
** Shares of Max Healthcare MAXE.NS rise about 2.5% to 954 rupees apiece
** The hospital chain on Friday announced an agreement with Lakshdeep Group to buy a 64% stake in Jaypee Healthcare at an enterprise value of 16.60 bln rupees ($198.31 mln)
** Jaypee Healthcare is currently undergoing the corporate insolvency resolution process
** Acquisition expands presence of MAXE in Noida and is in line with the strategy to leverage cash to boost growth through inorganic initiatives, says Ambit
** Brokerage terms it its second best pick in hospitals segment after Narayana Hrudayalaya NARY.NS
** The mean recommendation of 16 analysts tracking MAXE is "buy"; target price is at 947.50 rupees, around current levels - LSEG data
** Stock up 39% in 2024 so far, mirroring the performance of Nifty healthcare index .NIFHEIN - Exchange data
($1 = 83.7080 Indian rupees)
(Reporting by Bharath Rajeswaran in Bengaluru)
(([email protected]; +91 9769003463;))
Jaiprakash Associates Executes Non-Binding Term Sheet For Restructuring Of Bonds
Feb 27 (Reuters) - Jaiprakash Associates Ltd JAIA.NS:
EXECUTED A NON-BINDING TERM SHEET FOR RESTRUCTURING OF BONDS
Source text for Eikon: ID:nBSEZh3y
Further company coverage: JAIA.NS
(([email protected];))
Feb 27 (Reuters) - Jaiprakash Associates Ltd JAIA.NS:
EXECUTED A NON-BINDING TERM SHEET FOR RESTRUCTURING OF BONDS
Source text for Eikon: ID:nBSEZh3y
Further company coverage: JAIA.NS
(([email protected];))
Jaiprakash Associates Dec-Quarter Consol Net Loss After Tax Widens
Jan 30 (Reuters) - Jaiprakash Associates Ltd JAIA.NS:
RE-APPOINTMENT OF MANOJ GAUR AS EXECUTIVE CHAIRMAN & CEO
DEC-QUARTER CONSOL NET LOSS AFTER TAX 4.76 BILLION RUPEES VERSUS LOSS 3.15 BILLION RUPEES
DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 15.03 BILLION RUPEES VERSUS 18.76 BILLION RUPEES
Source text for Eikon: ID:nNSE7l9j0L
Further company coverage: JAIA.NS
(([email protected];))
Jan 30 (Reuters) - Jaiprakash Associates Ltd JAIA.NS:
RE-APPOINTMENT OF MANOJ GAUR AS EXECUTIVE CHAIRMAN & CEO
DEC-QUARTER CONSOL NET LOSS AFTER TAX 4.76 BILLION RUPEES VERSUS LOSS 3.15 BILLION RUPEES
DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 15.03 BILLION RUPEES VERSUS 18.76 BILLION RUPEES
Source text for Eikon: ID:nNSE7l9j0L
Further company coverage: JAIA.NS
(([email protected];))
India's Dalmia Bharat firms on Motilal Oswal's "top pick 2024" call
** Shares of Dalmia Bharat DALB.NS up ~3.5%, while other cement maker's are flat to up 2%
** Motilal Oswal says DALB among its top picks for 2024
** Says optimistic on DALB's long-term outlook due to capacity increase plans; strong balance sheet; and focus on sustainable growth via higher blended cement, green energy mix
** Says DALB's underperformance in past six months vs most cement stocks mainly due to delay in buying Jaiprakash Associates' JAIA.NS cement assets and demand slowdown in east
** Says DALB's expected earnings improvement as well as scale, capacity growth (without balance sheet leverage) to boost stock's multiples
** Brokerage reiterates "buy" and 2,800 rupees TP, vs current stock price of 2,357.30 rupees
** Avg rating of 27 brokers on DALB is also equivalent of "buy" but median TP is lower at 2,525 rupees - LSEG data
(Reporting by Dimpal Gulwani in Bengaluru)
** Shares of Dalmia Bharat DALB.NS up ~3.5%, while other cement maker's are flat to up 2%
** Motilal Oswal says DALB among its top picks for 2024
** Says optimistic on DALB's long-term outlook due to capacity increase plans; strong balance sheet; and focus on sustainable growth via higher blended cement, green energy mix
** Says DALB's underperformance in past six months vs most cement stocks mainly due to delay in buying Jaiprakash Associates' JAIA.NS cement assets and demand slowdown in east
** Says DALB's expected earnings improvement as well as scale, capacity growth (without balance sheet leverage) to boost stock's multiples
** Brokerage reiterates "buy" and 2,800 rupees TP, vs current stock price of 2,357.30 rupees
** Avg rating of 27 brokers on DALB is also equivalent of "buy" but median TP is lower at 2,525 rupees - LSEG data
(Reporting by Dimpal Gulwani in Bengaluru)
Jaiprakash Associate Says Out Of Total Borrowings Only 41.93 Bln Rupees Overdue as of Nov. End
Dec 6 (Reuters) - Jaiprakash Associates Ltd JAIA.NS:
TOTAL BORROWING OF CO IS 290.37 BILLION RUPEES REPAYABLE BY 2037
OUT OF TOTAL BORROWINGS ONLY 41.93 BILLION RUPEES IS OVERDUE AS ON 30.11.2023
OUT OF TOTAL BORROWINGS 185.18 BILLION RUPEES WILL GET REDUCED ON TRANSFER TO THE PROPOSED SPV
POST PROPOSED DIVESTMENT OF CEMENT BUSINESS, RESTRUCTURING BORROWING WILL GET ALMOST TO NIL
Source text for Eikon: ID:nNSEbWfgd0
Further company coverage: JAIA.NS
(([email protected];))
Dec 6 (Reuters) - Jaiprakash Associates Ltd JAIA.NS:
TOTAL BORROWING OF CO IS 290.37 BILLION RUPEES REPAYABLE BY 2037
OUT OF TOTAL BORROWINGS ONLY 41.93 BILLION RUPEES IS OVERDUE AS ON 30.11.2023
OUT OF TOTAL BORROWINGS 185.18 BILLION RUPEES WILL GET REDUCED ON TRANSFER TO THE PROPOSED SPV
POST PROPOSED DIVESTMENT OF CEMENT BUSINESS, RESTRUCTURING BORROWING WILL GET ALMOST TO NIL
Source text for Eikon: ID:nNSEbWfgd0
Further company coverage: JAIA.NS
(([email protected];))
Jaiprakash Associates Sept-Quarter Consol Net Loss After Tax 2.46 Bln Rupees
Nov 9 (Reuters) - Jaiprakash Associates Ltd JAIA.NS:
JAIPRAKASH ASSOCIATES LTD SEPT-QUARTER CONSOL NET LOSS AFTER TAX 2.46 BILLION RUPEES VERSUS LOSS 3.35 BILLION RUPEES
JAIPRAKASH ASSOCIATES LTD SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 18.96 BILLION RUPEES VERSUS 18.20 BILLION RUPEES
Source text for Eikon: ID:nBSEbZ3nrF
Further company coverage: JAIA.NS
(([email protected];))
Nov 9 (Reuters) - Jaiprakash Associates Ltd JAIA.NS:
JAIPRAKASH ASSOCIATES LTD SEPT-QUARTER CONSOL NET LOSS AFTER TAX 2.46 BILLION RUPEES VERSUS LOSS 3.35 BILLION RUPEES
JAIPRAKASH ASSOCIATES LTD SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 18.96 BILLION RUPEES VERSUS 18.20 BILLION RUPEES
Source text for Eikon: ID:nBSEbZ3nrF
Further company coverage: JAIA.NS
(([email protected];))
Adani Group In Discussions With Jaiprakash To Acquire Jaypee Shahabad Cement Plant- ET Now
Oct 18 (Reuters) -
ADANI GROUP IN DISCUSSIONS WITH JAIPRAKASH TO ACQUIRE JAYPEE SHAHABAD CEMENT PLANT- ET NOW
Source https://tinyurl.com/3c6h845v
(([email protected];))
Oct 18 (Reuters) -
ADANI GROUP IN DISCUSSIONS WITH JAIPRAKASH TO ACQUIRE JAYPEE SHAHABAD CEMENT PLANT- ET NOW
Source https://tinyurl.com/3c6h845v
(([email protected];))
India's Dalmia Bharat falls; brokerages flag lost market share
** Shares of cement manufacturer Dalmia Bharat DALB.NS fall as much as 4.1% to 2,226.15 rupees, mark sharpest intraday pct loss since Aug. 14
** Nomura says DALB lost market share in Q2, especially in the east; believes co will struggle to regain market share in FY24; downgrades DALB to "neutral" from "buy", TP at 2,600 rupees
** Jefferies says DALB volume growth is likely below industry growth in Q2, maintains "buy" while raising TP to 2,680 rupees from 2,440 rupees
** Ambit Insights believes till the deal to acquire cement business of Jaiprakash Associates JAIA.NS is completed, concerns of competing bids remains
** Believes industry's pricing power should sustain through 4QFY24, but will be temporary due to post-election demand moderation among others in FY25
** DALB on Saturday reported 156.5% Y/Y rise in Q2 consolidated net profit while rev rose 6% Y/Y
(Reporting by Ashish Chandra in Bengaluru)
(([email protected] (+91 7982114624))
** Shares of cement manufacturer Dalmia Bharat DALB.NS fall as much as 4.1% to 2,226.15 rupees, mark sharpest intraday pct loss since Aug. 14
** Nomura says DALB lost market share in Q2, especially in the east; believes co will struggle to regain market share in FY24; downgrades DALB to "neutral" from "buy", TP at 2,600 rupees
** Jefferies says DALB volume growth is likely below industry growth in Q2, maintains "buy" while raising TP to 2,680 rupees from 2,440 rupees
** Ambit Insights believes till the deal to acquire cement business of Jaiprakash Associates JAIA.NS is completed, concerns of competing bids remains
** Believes industry's pricing power should sustain through 4QFY24, but will be temporary due to post-election demand moderation among others in FY25
** DALB on Saturday reported 156.5% Y/Y rise in Q2 consolidated net profit while rev rose 6% Y/Y
(Reporting by Ashish Chandra in Bengaluru)
(([email protected] (+91 7982114624))
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does JP Associate do?
Jaiprakash Associates Limited (JAL) is an Indian infrastructure conglomerate involved in sectors like engineering, construction, power, cement, real estate, hospitality, expressways, and sports/education, with a focus on hydropower projects and cement production.
Who are the competitors of JP Associate?
JP Associate major competitors are Zuari Agro Chemicals, Khaitan Chem & Fert., Rama Phosphates, Madras Fertilizers, Aries Agro, Nagarjuna Fertilizer, Bharat Agri Fert. Market Cap of JP Associate is ₹871 Crs. While the median market cap of its peers are ₹420 Crs.
Is JP Associate financially stable compared to its competitors?
JP Associate seems to be less financially stable compared to its competitors. Altman Z score of JP Associate is 0.32 and is ranked 7 out of its 8 competitors.
Does JP Associate pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. JP Associate latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has JP Associate allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Inventory, Accounts Receivable
How strong is JP Associate balance sheet?
JP Associate balance sheet is weak and might have solvency issues
Is the profitablity of JP Associate improving?
The profit is oscillating. The profit of JP Associate is -₹2,821.96 Crs for TTM, -₹1,340 Crs for Mar 2024 and -₹1,341.83 Crs for Mar 2023.
Is the debt of JP Associate increasing or decreasing?
Yes, The debt of JP Associate is increasing. Latest debt of JP Associate is ₹13,541 Crs as of Sep-24. This is greater than Mar-24 when it was ₹13,112 Crs.
Is JP Associate stock expensive?
JP Associate is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE. Latest PE of JP Associate is 0.0, while 3 year average PE is 0.15. Also latest EV/EBITDA of JP Associate is 51.0 while 3yr average is 36.83.
Has the share price of JP Associate grown faster than its competition?
JP Associate has given lower returns compared to its competitors. JP Associate has grown at ~-15.3% over the last 8yrs while peers have grown at a median rate of 10.21%
Is the promoter bullish about JP Associate?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in JP Associate is 30.23% and last quarter promoter holding is 30.23%.
Are mutual funds buying/selling JP Associate?
The mutual fund holding of JP Associate is stable. The current mutual fund holding in JP Associate is 0.02% while previous quarter holding is 0.02%.